Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (3) Blankenstein, Thomas Prof. Dr. (2) Conrad, Thomas Dr. (1) Haas, Simon Dr. rer. nat. (1) Janz, Martin Dr. (1) Keller, Ulrich Dr. med. (3) Mathas, Stephan Dr. (1) Na, Il-Kang Dr. (69) Obermayer-Wasserscheid, Benedikt Dr. (3) Pezzutto, Antonio Prof. Dr. (1) Strzelecka, Paulina Maria (1) Walther, Wolfgang Prof. Dr. (1) (-) Schmitt, Clemens Prof. Dr. (3) 2019 (1) 2021 (1) 2022 (1) AG Müller/Dechend (ECRC) (42) AG Schreiber [ECRC] (1) Animal Phenotyping (6) Bioinformatics and Omics Data Science (1) Biology of Malignant Lymphomas (3) Cancer Genetics and Cellular Stress Responses (89) Cardiac MRI (1) Cellular Neurosciences (1) Clinical Research Unit (1) Developmental Biology / Signal Transduction (1) Electron Microscopy (1) Experimental Ultrahigh-Field MR (4) Genetics and Genomics of Cardiovascular Diseases (1) Genomics (1) Host-microbiome factors in cardiovascular disease (1) Hypertension-caused End-Organ Damage (42) Hypertension-Mediated End-Organ Damage (42) (-) Immune Dysregulations in Oncology (3) Intracellular Proteolysis (3) Magnetic Resonance (4) Mechanism-based Cancer Therapies (2) Microenvironmental Regulation in Autoimmunity and Cancer (1) Mobile DNA (1) Molecular Biology of Peptide Hormones (13) Molecular Genetics of Chronic Inflammation and Allergic Disease (1) Molecular Immunology and Gene Therapy (1) Myology (1) Neuroimmunology Laboratory (1) Out-patient Clinic for Neuroimmunology (3) Out-patient Clinic for Pediatric Allergology and Atopic Dermatitis (1) Protein Production and Characterization (2) Proteome Dynamics (1) Proteomics (2) Proteomics and Metabolomics (2) Psychoneuroimmunology (1) RNA Biology and Posttranscriptional Regulation (1) Structural Biology of Membrane-Associated Processes (1) Translational Bioinformatics (1) Translational Oncology of Solid Tumors (3) Tumor heterogeneity and treatment resistance in pediatric cancer (7) 3 Results: Active Filter: Schmitt, Clemens Prof. Dr.Immune Dysregulations in Oncology Sort: Result score Newest to oldest Oldest to newest December 19, 2019 / Int J Hematol Oncol A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response S. Denker A. Bittner I.K. Na J. Kase M. Frick I. Anagnostopoulos M. Hummel C.A. Schmitt August 01, 2021 / Leuk Lymphoma Cerebral EBV-positive PTLD controlled by PD-1 checkpoint blockade in a liver transplant patient A. Bittner J. Radke D. Eurich E. Wiener S. Denker I. Anagnostopoulos I.K. Na F.L. Heppner L. Bullinger C.A. Schmitt January 01, 2022 / Leuk Lymphoma Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals S. Denker A. Bittner M. Frick J. Kase J. Hoffmann C. Trenker U. Keller C. Bogner A. Hüttmann J. Dürig M. Janz S. Mathas R. Marks U. Krohn I.K. Na L. Bullinger C.A. Schmitt
December 19, 2019 / Int J Hematol Oncol A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response S. Denker A. Bittner I.K. Na J. Kase M. Frick I. Anagnostopoulos M. Hummel C.A. Schmitt
August 01, 2021 / Leuk Lymphoma Cerebral EBV-positive PTLD controlled by PD-1 checkpoint blockade in a liver transplant patient A. Bittner J. Radke D. Eurich E. Wiener S. Denker I. Anagnostopoulos I.K. Na F.L. Heppner L. Bullinger C.A. Schmitt
January 01, 2022 / Leuk Lymphoma Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals S. Denker A. Bittner M. Frick J. Kase J. Hoffmann C. Trenker U. Keller C. Bogner A. Hüttmann J. Dürig M. Janz S. Mathas R. Marks U. Krohn I.K. Na L. Bullinger C.A. Schmitt